Objectives: The American Diabetes Association recommends measuring hemoglobin A1C levels (A1C) at least semiannually in diabetic patients who have stable glycemic control and quarterly in patients whose therapy has changed or who are not meeting glycemic goals. These guidelines were based on expert consensus without reference to actual clinical data. The main objective of this study was to assess association between meeting a target A1C level of <7% and adherence to monitoring guidelines. Secondary objectives were to determine the proportion of diabetic patients in the authors' practice who met the A1C monitoring guidelines and to assess whether meeting the target A1C level is associated with other information easily abstracted from patients records, namely age, gender, and types of therapy. Methods: This study employed a case control design. Records of 193 type 2 diabetic patients seen over a 6-month period in a rural family medicine clinic were analyzed. Assessment of diabetes control was based on the most recent A1C level, with <7% considered controlled. Adherence to guidelines was assessed by determining frequency of testing during the preceding 12-month period. Results: Ninety-eight patients (51%) adhered to the American Diabetes Association guidelines on frequency of monitoring A1C. Median levels of adherent and nonadherent patients differed significantly (6.5 vs 7.3, P < .001, Mann-Whitney test). Logistic regression analysis showed that "diabetes control" based on the A1C level is positively associated with adherence to the guidelines, negatively associated with intensity of therapy, and not associated with gender or age. Conclusion: This study supports the usefulness of American Diabetes Association practice guidelines on the frequency of monitoring A1C levels in diabetic patients.
Percentage glycosylated hemoglobin A1C (A1C) is widely used for monitoring blood sugar levels in diabetic patients. Guidelines published by the American Diabetes Association (ADA) recommend that treatment for diabetes aim for A1C < 7%, and about half of all Americans with diabetes achieve this level. 1 It is generally believed that achieving a target level depends on the frequency of monitoring, and the ADA recommends obtaining an A1C level at least twice yearly in patients who are meeting treatment goals and who have sta ble glycemic control and quarterly in patients whose ther apy has changed or who are not meeting treatment goals. 2 However, these guidelines were based on expert consensus and clinical experience, and the evidence is considered level E; no study has been found to validate these guidelines. Fur thermore, discussions of frequency of testing have voiced concerns about undertesting and overtesting. 3 The main objective of this study was to test the premise that persons who adhered to the guidelines would have better control. We also wished to determine what fraction of our patients were compliant with the guidelines and whether meeting target A1C level of <7% correlates with other infor mation easily abstracted from patients records, namely age, gender, and types of therapy.
Methods
Our clinic service area in the twin tiers region of Pennsylvania and New York is largely rural, and the population is 97% white. Health care is provided by family medicine physicians and residents, as well as by physician assistants. This study employed a retrospective case control design. All encounters between January 1, 2009 and June 30, 2009 with patients having a primary diagnosis of type 2 diabetes were considered. Patients were seen primarily for treatment adjustments and/or followup of diabetes evalu ations. Each patient's electronic medical record was reviewed, and the latest A1C level was used to classify the diabetes as either controlled (<7%) or uncontrolled (≥7%). Patients were considered adherent to the guidelines if in the preceding 12month period, any A1C test reporting a level < 7.0% was followed by another test within 6 months, and any test reporting a level ≥7.0% was followed by another test within 3 to 4 months. Because many factors can affect compliance with a monitoring schedule, A1C levels obtained within 4month intervals were considered accept able. Lyon et al have commented that emphasizing a tight time frame for testing at 3month intervals may overesti mate the number of patients who are not adherent to guide lines. 3 Deceased patients, patients with gestational diabetes or type 1 diabetes, patents whose records showed no A1C levels or only with pointofcare testing, and patients with anemia were excluded from the study. Other possible rea sons for not complying with the frequency of monitoring A1C guidelines were not considered exclusionary factors. These included availability of transportation, transfer to another provider outside of our health system, sche duled activities and appointment issues, provider's know ledge of the guidelines, insurance issues, laboratory errors, and medication changes. Types of therapy, gender, and age were recorded. Intensity of therapy was assigned a value between 0 and 5: No drugs was coded as 0; 1, 2, or ≥3 oral hypoglycemic drugs were coded as 1, 2, or 3, respec tively; insulin alone was coded as 4; and insulin plus oral medication(s) was coded as 5. SigmaPlot version 11 (Systat Software, Inc, Chicago, Illinois) was used to analyze data. This study was approved by the Guthrie Healthcare System Institutional Review Board.
Results
One hundred ninetythree patients (88 men, 105 women) with a primary diagnosis of type 2 diabetes were eligible for the study. Patients' ages ranged from 26 to 92 years, with a median age of 60 years ( Table 1 ). The male/female ratio of 0.84 (95% confidence interval, 0.760.90) is slightly but not significantly lower than the ratio of 0.91 for 482 subjects reported in the 20032004 National Health and Nutrition Examination Survey 4 and slightly higher than the ratio of 0.73 for a rural cohort studied by Glasser et al. 5 Ninetyeight patients (51%) met the frequency monitor ing guidelines, and 84 of them were controlled diabetics based on their A1C levels of <7% (Figure 1 ). Ninetyfive patients did not meet the monitoring guidelines, and 65 of them had uncontrolled diabetes with A1C ≥ 7%. Median A1C values of patients who adhered to guidelines were sig nificantly lower than were the median values of patients who did not adhere to the guidelines (MannWhitney test, P < .001). In all, 58% (95% confidence interval, 51%65%) of our patients had A1C levels indicating good control of diabetes, which is consistent with population estimates of 57% reported in the 20032004 National Health and Nutrition Examination Survey. 4 There was no significant difference between the male/female ratios of the adherent and nonadher ent groups (0.81 and 0.86, respectively).
Univariate analysis showed a significant and very strong association between the control of A1C and adherence to ADA guidelines (odds ratio [OR], 13). Further univariate analysis suggested that intensity of therapy is strongly but negatively associated with diabetes control (OR, 0.62); age is positively but weakly associated with diabetes control (OR, 1.03); and gender is not associated ( Table 2) . Multiple logistic regression and forward and backward stepwise reg ression revealed that of the original 4 variables tested, only adherence to guidelines and intensity of therapy are inde pendent correlates of control.
Discussion
This study showed that patients in our rural primary care practice who adhered to ADA guidelines for frequency of monitoring hemoglobin A1C had better diabetes control than did those who did not, and it provides strong empirical support for the guidelines. This relationship is independent of intensity of therapy, age, and gender. The negative cor relation of glycemic control with intensity of therapy and the lack of correlation with gender have been reported by others who studied larger populations. 4, 68 Furthermore, the gender distribution of our patients and the percentage who are controlled are consistent with other reports. 4, 5 A notable difference is that we did not observe the positive associa tion of control with age noted by others. 4, 8 The observed adherence rate of 51% is probably an overestimate because our study protocol would have missed diabetic patients who should have been evaluated during the 6month study period (JanuaryJune 2009) but, for whatever reason, did not keep appointments. Nevertheless, the relatively low rate of patients who are following the guidelines suggests that a major edu cational intervention to increase adherence would be efficacious. As noted previously, our clinic population is over whelmingly white, which, although significantly dif ferent from the populations studied by others, 4, 8 is typical of many rural areas in United States. 5 Adherence to guide lines among nonwhite groups might be a profitable area of future research.
The study is subject to the limitations common to case control studies, and finding an association between adherence to guidelines and A1C levels cannot be said to demonstrate a causal link. On the other hand, a finding of no ass ociation would have raised at least some question about the efficacy of the guidelines. 
